drug protocol number

19-504

drug sponsor

King Abdullah Medical City, Holy Capital

drug study

• PANITUMUMAB• OXALIPLATIN• irinotecan• FLOUROURACIL

drug trial site

King Abdullah Medical City (Makkah)

drug status

Ongoing

drug phase